Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

cbdMD (YCBD) Receivables (2016 - 2025)

cbdMD (YCBD) has disclosed Receivables for 10 consecutive years, with $744662.0 as the latest value for Q4 2025.

  • Quarterly Receivables rose 18.01% to $744662.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $744662.0 through Dec 2025, up 18.01% year-over-year, with the annual reading at $1.0 million for FY2025, 5.79% up from the prior year.
  • Receivables hit $744662.0 in Q4 2025 for cbdMD, down from $1.0 million in the prior quarter.
  • In the past five years, Receivables ranged from a high of $2.0 million in Q1 2022 to a low of $338502.0 in Q1 2023.
  • Historically, Receivables has averaged $1.1 million across 5 years, with a median of $1.0 million in 2024.
  • Biggest five-year swings in Receivables: skyrocketed 179.0% in 2021 and later crashed 83.45% in 2023.
  • Year by year, Receivables stood at $1.1 million in 2021, then dropped by 18.95% to $898720.0 in 2022, then crashed by 35.81% to $576901.0 in 2023, then rose by 9.38% to $631033.0 in 2024, then increased by 18.01% to $744662.0 in 2025.
  • Business Quant data shows Receivables for YCBD at $744662.0 in Q4 2025, $1.0 million in Q3 2025, and $967310.0 in Q2 2025.